terodiline has been researched along with Torsade de Pointes in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (86.67) | 18.2507 |
2000's | 1 (6.67) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Campbell, RW; Ford, GA; Hartigan-Go, K; Higham, PD; Kamali, F; Thomas, SH; Wood, P | 1 |
Botstein, P | 1 |
Daly, AK; Ford, GA; Wood, SM | 1 |
Stricker, BH; van der Klauw, MM; van Rey, FJ | 1 |
Ohmsen, E; Pedersen, JL | 1 |
Andersen, M; Kristensen, D | 1 |
Lycklama à Nijeholt, AA | 1 |
Braadland, H | 1 |
Astridge, PS; Connolly, MJ; Cowan, JC; Morley, CA; White, EG | 1 |
Offerhaus, L | 1 |
1 trial(s) available for terodiline and Torsade de Pointes
Article | Year |
---|---|
Effects of terodiline on urinary incontinence among older non-institutionalized women. Terodiline in the Elderly American Multicenter Study Group.
Topics: Aged; Aged, 80 and over; Ambulatory Care Facilities; Butylamines; Diabetes Complications; Double-Blind Method; Female; Humans; Linear Models; Middle Aged; Parasympatholytics; Time Factors; Torsades de Pointes; Urinary Incontinence; Urodynamics | 1993 |
14 other study(ies) available for terodiline and Torsade de Pointes
Article | Year |
---|---|
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence.
Topics: Aged; Aged, 80 and over; Butylamines; Calcium Channel Blockers; Electrocardiography; Humans; Middle Aged; Parasympatholytics; Torsades de Pointes; Urinary Incontinence | 1995 |
Is QT interval prolongation harmful? A regulatory perspective.
Topics: Astemizole; Butylamines; Electrocardiography; Humans; Terfenadine; Torsades de Pointes; Urinary Incontinence | 1993 |
CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card system.
Topics: Aged; Aged, 80 and over; Alleles; Aryl Hydrocarbon Hydroxylases; Butylamines; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; DNA; Female; Follow-Up Studies; Gene Frequency; Genotype; Heart; Humans; Male; Mixed Function Oxygenases; Parasympatholytics; Polymerase Chain Reaction; Polymorphism, Genetic; Tachycardia, Ventricular; Torsades de Pointes | 2000 |
[Polymorph ventricular tachycardia with torsades de pointes caused by administration of terodiline (Mictrol)].
Topics: Butylamines; Calcium Channel Blockers; Cardiac Complexes, Premature; Cystitis; Female; Humans; Middle Aged; Tachycardia; Torsades de Pointes | 1992 |
[Torsades de pointes ventricular tachycardia caused by terodiline (Mictrol)?].
Topics: Aged; Butylamines; Humans; Long QT Syndrome; Male; Torsades de Pointes | 1992 |
[Ventricular tachycardia caused by terodiline].
Topics: Aged; Butylamines; Calcium Channel Blockers; Female; Humans; Male; Middle Aged; Torsades de Pointes | 1992 |
[Polymorph ventricular tachycardia with torsades de pointes in administration of terodiline (Mictrol)].
Topics: Butylamines; Calcium Channel Blockers; Humans; Parasympatholytics; Tachycardia; Torsades de Pointes; Urinary Incontinence, Stress | 1992 |
[Torsades de pointes heart arrhythmia caused by terodiline].
Topics: Aged; Butylamines; Calcium Channel Blockers; Female; Humans; Pacemaker, Artificial; Torsades de Pointes | 1992 |
Torsades de pointes ventricular tachycardia and terodiline.
Topics: Aged; Aged, 80 and over; Butylamines; Female; Humans; Male; Middle Aged; Parasympatholytics; Torsades de Pointes | 1991 |
Torsades de pointes and terodiline.
Topics: Aged; Butylamines; Humans; Parasympatholytics; Torsades de Pointes | 1991 |
Terodiline and torsades de pointes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Butylamines; Child; Child, Preschool; Electrocardiography; Humans; Middle Aged; Parasympatholytics; Product Surveillance, Postmarketing; Torsades de Pointes; Urinary Incontinence | 1991 |
[Mictrol is withdrawn after adverse cardiac effects. An account of Swedish cases].
Topics: Aged; Butylamines; Calcium Channel Blockers; Female; Humans; Parasympatholytics; Torsades de Pointes | 1991 |
[Foreign report on side effects of drugs].
Topics: Australia; Butylamines; Drug-Related Side Effects and Adverse Reactions; England; Humans; Parasympatholytics; Sweden; Torsades de Pointes | 1991 |